Shield Diagnostics
Latest round
- Series A
Last raised
- May 2018
Total raised
- $8.8M
Investors
- 4
About Shield Diagnostics
, aka Shield Bio, is a company designed to combat the global threat of antibiotic resistance and revolutionizing infectious disease treatment. Fred Turner and Sam Parlett are the co-founders of the company. The company's primary focus is the development of rapid and accurate molecular antibiotic susceptibility testing through its Target-X platform. The firm’s cutting-edge technology enables swift and precise identification of the infectious agent and associated antibiotic susceptibility genes, eliminating the need for time-consuming culture tests. Shield Bio's flagship product, Target-NG, focuses on identifying the sensitivity of N. gonorrhoeae infections to ciprofloxacin.
Who invested in Shield Diagnostics
4 investors across 2 rounds
See all investors in Shield Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shield Diagnostics
Who invested in Shield Diagnostics?
Shield Diagnostics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shield Diagnostics raised?
Shield Diagnostics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Shield Diagnostics last raise money?
Shield Diagnostics's most recent round on record is a Series A, in May 2018.
What does Shield Diagnostics do?
, aka Shield Bio, is a company designed to combat the global threat of antibiotic resistance and revolutionizing infectious disease treatment.
Where is Shield Diagnostics headquartered?
Shield Diagnostics is headquartered in San Jose, US.
Which VCs invest in companies like Shield Diagnostics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Shield Diagnostics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Shield Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.